A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps

NCT06516302 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

228

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Interventions

DRUG: GR1802
DRUG: Placebo

Sponsor

Genrix (Shanghai) Biopharmaceutical Co., Ltd.